Peripheral blood neutrophil count as a prognostic factor for patients with hepatocellular carcinoma treated with sorafenib | |
Yuan, Jia; Liang, Hongming; Li, Jinghuan; Li, Miao; Tang, Bei; Ma, Hui; Xie, Xiaoying; Yin, Xin; Zhang, Lan; Ren, Zhenggang | |
刊名 | MOLECULAR AND CLINICAL ONCOLOGY |
2017 | |
卷号 | 7期号:5 |
关键词 | hepatocellular carcinoma sorafenib peripheral neutrophils prognosis nomogram |
ISSN号 | 2049-9450 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3620184 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Yuan, Jia,Liang, Hongming,Li, Jinghuan,et al. Peripheral blood neutrophil count as a prognostic factor for patients with hepatocellular carcinoma treated with sorafenib[J]. MOLECULAR AND CLINICAL ONCOLOGY,2017,7(5). |
APA | Yuan, Jia.,Liang, Hongming.,Li, Jinghuan.,Li, Miao.,Tang, Bei.,...&Ren, Zhenggang.(2017).Peripheral blood neutrophil count as a prognostic factor for patients with hepatocellular carcinoma treated with sorafenib.MOLECULAR AND CLINICAL ONCOLOGY,7(5). |
MLA | Yuan, Jia,et al."Peripheral blood neutrophil count as a prognostic factor for patients with hepatocellular carcinoma treated with sorafenib".MOLECULAR AND CLINICAL ONCOLOGY 7.5(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论